Literature DB >> 7931066

Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.

P Silacci1, A Mottet, V Steimle, W Reith, B Mach.   

Abstract

Constitutive major histocompatibility complex (MHC) class II gene expression is tightly restricted to antigen presenting cells and is under developmental control. Cells of the B cell lineage acquire the capacity to express MHC class II genes early during ontogeny and lose this property during terminal differentiation into plasma cells. Cell fusion experiments have suggested that the extinction of MHC class II expression in plasma cells is due to a dominant repression, but the underlying mechanisms are not understood. CIITA was recently identified as an MHC class II transactivator that is essential for MHC class II expression in B lymphocytes. We show here that inactivation of MHC class II genes in plasmocytes is associated with silencing of the CIITA gene. Moreover, experimentally induced expression of CIITA in plasmocytes leads to reexpression of MHC class II molecules to the same level as that observed on B lymphocytes. We therefore conclude that the loss of MHC class II expression observed upon terminal differentiation of B lymphocytes into plasmocytes results from silencing of the transactivator gene CIITA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931066      PMCID: PMC2191691          DOI: 10.1084/jem.180.4.1329

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

Review 1.  Regulation of human B-cell ontogeny.

Authors:  F M Uckun
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

Review 2.  Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet.

Authors:  C Benoist; D Mathis
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 3.  Regulated expression of cell surface antigens during B cell development.

Authors:  P D Burrows; M D Cooper
Journal:  Semin Immunol       Date:  1990-05       Impact factor: 11.130

Review 4.  Sequences and factors: a guide to MHC class-II transcription.

Authors:  L H Glimcher; C J Kara
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

5.  Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors.

Authors:  S Y Tsang; M Nakanishi; B M Peterlin
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

6.  Induction of HLA class II genes by IFN-gamma is transcriptional and requires a trans-acting protein.

Authors:  I Amaldi; W Reith; C Berte; B Mach
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

7.  Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters.

Authors:  W Reith; M Kobr; P Emery; B Durand; C A Siegrist; B Mach
Journal:  J Biol Chem       Date:  1994-08-05       Impact factor: 5.157

8.  Effects of different DNA polymerases in ligation-mediated PCR: enhanced genomic sequencing and in vivo footprinting.

Authors:  P A Garrity; B J Wold
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

9.  Transcriptional control of MHC class II gene expression during differentiation from B cells to plasma cells.

Authors:  P Dellabona; F Latron; A Maffei; L Scarpellino; R S Accolla
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

Review 10.  Clonal sketches of the immune response.

Authors:  A Lanzavecchia
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more
  38 in total

1.  CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.

Authors:  K Masternak; A Muhlethaler-Mottet; J Villard; M Zufferey; V Steimle; W Reith
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

Review 2.  Class II transactivator: mastering the art of major histocompatibility complex expression.

Authors:  J A Harton; J P Ting
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.

Authors:  S B Hake; K Masternak; C Kammerbauer; C Janzen; W Reith; V Steimle
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

Review 4.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

5.  MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.

Authors:  Christian Steidl; Sohrab P Shah; Bruce W Woolcock; Lixin Rui; Masahiro Kawahara; Pedro Farinha; Nathalie A Johnson; Yongjun Zhao; Adele Telenius; Susana Ben Neriah; Andrew McPherson; Barbara Meissner; Ujunwa C Okoye; Arjan Diepstra; Anke van den Berg; Mark Sun; Gillian Leung; Steven J Jones; Joseph M Connors; David G Huntsman; Kerry J Savage; Lisa M Rimsza; Douglas E Horsman; Louis M Staudt; Ulrich Steidl; Marco A Marra; Randy D Gascoyne
Journal:  Nature       Date:  2011-03-02       Impact factor: 49.962

6.  CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo.

Authors:  K L Wright; K C Chin; M Linhoff; C Skinner; J A Brown; J M Boss; G R Stark; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Repression of MHC class II gene transcription in trophoblast cells by novel single-stranded DNA binding proteins.

Authors:  S P Murphy; S O Gollnick; T Pazmany; P Maier; G Elkin; T B Tomasi
Journal:  Mol Reprod Dev       Date:  1997-08       Impact factor: 2.609

8.  Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy.

Authors:  S Bontron; C Ucla; B Mach; V Steimle
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

9.  The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

Authors:  J A Brown; E M Rogers; J M Boss
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

10.  Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.

Authors:  H T Lu; J L Riley; G T Babcock; M Huston; G R Stark; J M Boss; R M Ransohoff
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.